Product name: Soyasaponin Bb
Synonym name: Soyasaponin I
Catalogue No.: BP1332
Cas No.: 51330-27-9
Formula: C₄₈H₇₈O₁₈
Mol Weight: 943.134
Botanical Source: Glycine max
Physical Description:
Type of Compound: Triterpenoids

Purity: 95%~99%
Analysis Method: HPLC-DAD or/and HPLC-ELSD
Identification Method: Mass, NMR
Packing: Brown vial or HDPE plastic bottle

Storage: Store in a well closed container, protected from air and light. Put into refrigerate or freeze for long term storage.
Whenever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20℃. Generally, these will be useable for up to two weeks.

The product could be supplied from milligrams to grams
Inquire for bulk scale.

Description:

Soyasaponin Bb can suppress Eca-9706 cell growth, reverse effects on over expression of c-met, VEGF, and induce cell apoptosis through inhibiting HDAC1-NF-kappaB and activating PETEN and caspase-3 signaling pathways.

References:

Wei Sheng Yan Jiu. 2010 Jul;39(4):444-6.    

Apoptosis effects on human esophageal cancer cells by soyasaponin Bb and its machanism.   

To explore the effect and potential mechanism of apoptosis in the Eca-9706 cells induced by Soyasaponin Bb. 

METHODS AND RESULTS:

Different concentrations of Soyasaponin Bb were on the Eca-9706 cell. Cell growth suppression rate was detected by MTT. Apoptotic rate was detected by TUNEL. The expression changes of HDAC1, NF-kappaB, PTEN, cyclin D1, c-met, VEGF or caspase-3 in the SSBb were detected by immunohistochemistry and immunoblotting. Compared with the control group, the growth-inhibition rate and apoptotic rate were increased, the expressions of PTEN, caspase 3 were increased, the expressions of c-met, VEGF, HDAC1, NF-kappaB and cyclin D1 were decreased. 

CONCLUSIONS:

SSBb can suppress Eca-9706 cell growth. SSBb can exhibit reverse effects on over expression of c-met, VEGF in Eca-9706 cells. Eca-9706 cell apoptosis can be induced by SSBb through inhibiting HDAC1-NF-kappaB and activating PETEN and caspase-3 signaling pathways.    

HPLC of  Soyasaponin Bb

Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃

Introduction/Overview

Soybean saponin Bb (Soyasaponin Bb) is a class of natural triterpene saponins derived from soybeans (Glycine max). Due to their diverse biological activities and potential medicinal value, they have attracted widespread attention in the field of natural product pharmacology in recent years. As an orally effective covalent heme oxygenase-1 (HO-1) inducer and aldose reductase (AKR1B1) inhibitor, Soy Saponin Bb demonstrates significant pharmacological effects in regulating oxidative stress, anti-inflammatory, hepatprotective, and neuroprotective effects. By regulating intracellular antioxidant pathways, reducing reactive oxygen species (ROS) production, and inhibiting lipid peroxidation and hepatocyte apoptosis, it demonstrates excellent tissue protection, especially showing significant therapeutic potential in models of alcohol-induced liver injury and scopolamine-induced cognitive impairment.

In addition, research on the lipid-lowering effect of soybean saponin Bb has been deepening, with related targets including cholesterol ester transfer protein (CETP), 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), low-density lipoprotein receptor (LDLR), apolipoprotein B (APOB), proproprotein converting enzyme lysozyme 9 (PCSK9), apolipoprotein E (APOE), and peroxisome proliferator-activated receptor α (PPARA), among others. Demonstrates its potential value in regulating lipid metabolism and preventing cardiovascular diseases. This paper will systematically review the chemical structure, origin, pharmacological activity, mechanism of action, druggability, and clinical application prospects of Soy Saponin Bb, aiming to provide a theoretical foundation and research direction for its subsequent development and application.

Chemical structure and physicochemical properties

Soy saponin Bb belongs to the triterpene saponin class of compounds, with a molecular formula of C_48H_78O_18 and a molecular weight of 943.1340 Da. Its structure consists of a triterpenoid parent nucleus connected by glycosidic bonds to multiple glycosidic groups, specifically including β-glucose and other monosaccharide residues. The compound has a LogP value of 2.2234, indicating moderate lipid solubility, which is beneficial for cell membrane penetration and bioavailability. TPSA (Topological Polar Surface Area) is 294.98 Ų. The relatively high polar surface area indicates average water solubility, with a water solubility of 0.2598, classifying it as a low-solubility compound.

The structural characteristics of soybean saponin Bb give it strong bioactivity, especially the glycoside portion, which plays a key role in binding to target proteins and regulating signaling pathways. Its ability to penetrate the blood-brain barrier is relatively low, suggesting that its direct role in the central nervous system may be limited, but it still holds potential through peripheral neuroprotective mechanisms or indirect regulation of central nervous system function. Additionally, this compound does not inhibit hERG channels, and the Ames-related mutagenicity test was negative, indicating high safety and a solid druggability foundation.

Plant Origins and Extraction Methods

Soy saponin Bb is mainly found in soybeans and their products, and is an important member of the soybean saponin family. As an important global grain and oil crop, soybeans are rich in saponins, especially high in the seed coat and germ parts. Traditionally, extraction of soy saponins has mostly relied on organic solvent extraction combined with column chromatography separation.

During extraction, 70% ethanol or methanol is commonly used as the extraction solvent, and ultrasound-assisted or reflux extraction techniques are used to improve the efficiency of saponin extraction. Subsequently, the crude extract was separated and purified by liquid-liquid partitioning, silica gel column chromatography, and reversed-phase high-performance liquid chromatography (RP-HPLC), ultimately obtaining high-purity soybean saponin Bb. Modern extraction processes are gradually introducing green and environmentally friendly methods such as supercritical CO_2 extraction and membrane separation technology to improve extraction efficiency and purity, while reducing production costs.

Moreover, with advances in biosynthetic pathway research, the use of genetic engineering to express soybean saponin Bb in microorganisms or plant cells as an alternative synthesis enzyme has become an important direction for future large-scale production with broad application prospects.

Pharmacological activity research

Antioxidant and anti-inflammatory activities

Numerous in vitro and in vivo studies have shown that soybean saponin Bb significantly enhances cellular antioxidant defense by inducing heme oxygenase-1 (HO-1) expression. HO-1, as an important intracellular antioxidant enzyme, can break down heme to produce products with antioxidant and anti-inflammatory effects, such as carbon monoxide (CO) and biliveruin (bilirubin). Soy saponin Bb covalently induces HO-1, reduces reactive oxygen species (ROS) generation, inhibits lipid peroxidation, and alleviates oxidative stress damage.

Additionally, soy saponin Bb can inhibit aldose reductase (AKR1B1), an enzyme that plays an important role in the development of diabetic complications. Its inhibition helps alleviate diabetic-related oxidative stress and inflammatory responses. Related studies show that soy saponin Bb significantly reduces the expression of inflammatory factors such as TNF-α and IL-6, alleviating tissue inflammatory responses.

Hepatoprotective effects

Alcoholic liver injury is a common type of liver disease in clinical practice, with oxidative stress and lipid peroxidation as its main pathogenesis. Soy saponin Bb enhances HO-1 expression and antioxidant enzyme activity, reduces ROS accumulation within hepatocytes, inhibits lipid peroxidation, protects liver cell membrane stability, and prevents hepatocyte apoptosis. Animal model studies have confirmed that soy saponin Bb significantly improves alcohol-induced liver dysfunction, lowers serum transaminase levels, and alleviates pathological damage to liver tissue.

Neuroprotective effects

In studies on neurodegenerative diseases and cognitive impairment, soybean saponin Bb has shown good neuroprotective activity. In the Scopolamine-induced memory impairment model, soybean saponin Bb improves cognitive function and reduces neuronal damage through antioxidant and anti-inflammatory mechanisms. Its low blood-brain barrier penetration suggests that its effects may be achieved by modulating the peripheral nervous system or indirectly affecting the central nervous system.

Lipid-lowering effect

Research on soy saponin Bb in regulating lipid metabolism is gradually increasing. Its targets include key molecules such as cholesterol ester transfer protein (CETP), HMGCR, LDLR, APOB, PCSK9, APOE, and PPARA, indicating that it can synergistically regulate cholesterol synthesis, transport, and metabolism through multiple targets, lower plasma low-density lipoprotein cholesterol (LDL-C) levels, improve dyslipidemia, and prevent atherosclerosis and cardiovascular diseases.

Mechanism of action and molecular targets

The pharmacological effects of soybean saponin Bb are attributed to its regulation of multiple signaling pathways and key targets:

1. HO-1 induction mechanism
   Soy saponin Bb promotes Nrf2 nuclear translocation by activating the Nrf2-ARE signaling pathway, enhancing HO-1 gene expression. HO-1 products have antioxidant, anti-inflammatory, and cell-protective effects, significantly reducing oxidative stress levels.

2. Aldose reductase (AKR1B1) inhibition
   AKR1B1 is involved in the occurrence of various diabetic complications. Soy saponin Bb acts as its inhibitor, blocking the polyol pathway, reducing the formation of glycosylation end products (AGEs), and alleviating diabetes-related tissue damage.

3. Regulation of lipid metabolism
   Soy saponin Bb affects cholesterol synthesis, transport, and receptor-mediated clearance by regulating targets such as CETP, HMGCR, LDLR, and PCSK9. PPARA activation promotes fatty acid oxidation, lowers blood lipid levels, and overall improves lipid metabolism.

4. Anti-inflammatory and anti-apoptotic effects
   By inhibiting the NF-κB signaling pathway, soybean saponin Bb reduces the expression of pro-inflammatory cytokines and suppresses inflammatory responses. At the same time, by regulating Bcl-2 family proteins, it inhibits apoptosis of liver cells and nerve cells, maintaining tissue homeostasis.

Druggability evaluation and pharmacokinetics

Soybean saponin Bb has a relatively large molecular weight (943.1340 Da) and a high TPSA (294.98 Ų), suggesting that oral absorption may be limited, but its moderate LogP value (2.2234) favors cell membrane permeability. Water solubility is relatively low (0.2598), which may affect bioavailability and requires formulation optimization or structural modification.

The blood-brain barrier has low penetration, limiting its direct effect on the central nervous system, but its protective effect on surrounding tissues remains significant. In terms of safety, soybean saponin Bb does not inhibit hERG channels, and Ames mutagenic tests are negative, indicating low cardiotoxicity and genotoxicity risks, providing a solid safety foundation.

Pharmacokinetic studies show that soy saponins (BB) are widely distributed in the body after oral administration, mainly metabolized by the liver, with a moderate half-life. Its metabolites may have certain biological activity, requiring further research into metabolic pathways and pharmacological effects of these metabolites.

Prospects and outlooks for clinical applications

Soy saponin Bb, with its multi-target and multi-pathway pharmacological properties, demonstrates broad clinical application potential in antioxidant, hepatoprotective, neuroprotection, and lipid-lowering fields. It holds significant therapeutic value especially in the prevention and treatment of alcoholic liver disease, diabetic complications, cognitive impairment, and cardiovascular diseases.

Future research should focus on the following aspects:

• Dosage form development and drug route optimization: To address poor water solubility and limited oral absorption, develop nanoformulations, liposomes, or other novel delivery systems to improve bioavailability and targeting.
• In-depth analysis of mechanisms of action: By combining multi-omics techniques, the molecular action network is comprehensively revealed, key targets and signaling pathways are identified, providing a basis for precision treatment.
• Pharmacokinetics and safety evaluation: Systematically assess its in vivo metabolic characteristics and long-term safety to ensure efficacy and safety in clinical application.
• Clinical trial validation: Conduct large-sample clinical studies to verify efficacy and safety in related diseases, driving clinical drug translation.

In addition, the design and synthesis of derivatives based on the structure of soybean saponin Bb will provide new ideas and means to enhance their efficacy and pharmacokinetic properties.

Conclusion

Soy saponin Bb, as a natural triterpene saponin with significant antioxidant, hepatprotective, neuroprotective, and lipid-lowering activities, demonstrates broad pharmacological effects and good safety, showing potential as an adjunct therapy for various chronic diseases. By regulating HO-1, AKR1B1, and various lipid metabolic targets, it exerts multi-layered protective effects, demonstrating the advantages of multi-target therapies derived from natural products.

In the future, with advances in extraction and purification technology, deeper analysis of mechanisms of action, and advancement of clinical research, Soy Saponin Bb is expected to become an important research subject and an emerging drug for clinical application in the field of natural product pharmacology. Ongoing basic and applied research will provide solid scientific support for its development, driving its widespread application in modern medicine.